Article: Pentostatin, Cyclophosphamide Together Show Excellent Activity And Tolerability.(Brief Article)

Article: SuperGen's Nipent 'Extremely Active' in Refractory Blood ...
PR Newswire;  November 13, 2000 ;     700+ words ... ... combination of pentostatin (Nipent) and Rituximab is "so ... study, using pentostatin (Nipent) and Cyclophosphamide ... Kettering Cancer Center in New York City. Dr. Weiss demonstrated that the pentostatin (Nipent) and Cyclophosphamide ...

Article: Data From Numerous Clinical Studies Cite Activity of ...
PR Newswire;  December 8, 2003 ;     700+ words ... ... Hematology (ASH) in San Diego. Nipent is currently approved as a ... combination therapy consisting of Nipent, cyclophosphamide and rituximab ... Cancer Therapy for Tomorrow" in New York City. (Abstract no. 2504 ... combination therapy consisting of Nipent, cyclophosphamide and rituximab ...

Article: Memorial Sloan-Kettering Cancer Center Phase I/II Study Concludes ...
PR Newswire;  November 13, 2001 ;     700+ words ... ... its anticancer drug pentostatin (Nipent) in combination with cyclophosphamide ... Sloan-Kettering Cancer Center in New York City, and the study's lead investigator ... enrolled and treated with a fixed dose of Nipent and one of two dose levels of cyclophosphamide ...

Article: SuperGen's $34M Sell-Off To Mayne Includes Nipent.
BIOWORLD Today;  November 3, 2009 ;     700+ words ... ... a deal worth $34 million. Nipent (pentostatin for injection ... original strategy when it bought Nipent from Warner-Lambert Co ... analyst Matthew Osborne, of New York-based Lazard Capital Markets ... the ex-U.S. rights of Nipent. Nipent earned SuperGen about ...

Article: Preliminary Results of a Study with Nipent(R), Rituxan(TM) ...
PR Newswire;  November 14, 2003 ;     700+ words ... ... of the anticancer compound Nipent(R) (pentostatin for injection ... Cancer Therapy for Tomorrow" in New York City. The Chemotherapy Foundation ... jointly sponsored the event. Nipent is currently approved as a ... having received a combination of Nipent (2 mg/m2), Rituxan (rituximab ...

Article: Immunosuppressive Agent Pentostatin Shows Promise.(Nipent ...
Drug Week;  July 27, 2001 ;     700+ words ... ... SUPGZ) announced that its drug Nipent [R] (pentostatin), which is ... Sloan-Kettering Cancer Center in New York City, New York. "Most impressive, however ... presented data from his study using Nipent in a mini-transplant regimen ...

Article: New England Medical Center Study Shows SuperGen's Pentostatin ...
PR Newswire;  November 14, 2001 ;     700+ words ... ... anticancer compound pentostatin (Nipent) shows that it is a major ... Cancer Therapy for Tomorrow" in New York City, which was co-sponsored ... continuous infusion of pentostatin (Nipent). Of 40 evaluable patients ... as supplementary evidence of Nipent's special ability to help ...